No profile data available.
Aspira Women's Health Inc. (AWHL) is a healthcare company in the DNA testing equipment industry, based in Austin, United States, with about 36 full-time employees.
It reported revenue of $9.22 million for fiscal year 2025, up 0.4% from fiscal year 2024, and net income of -$12.78 million. Its market capitalization was $12.12 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, together with its subsidiaries, discovers, develops, and commercializes of noninvasive AI-powered diagnostic tests for gynecologic diseases in the United States.
Aspira Women's Health reported $9.22 million in revenue for fiscal year 2025, up 0.4% from $9.18 million in fiscal year 2024.
$12.12 million as of October 9, 2026.
Listed companies of a similar size in the same industry (DNA testing equipment) include Sera Prognostics, Inc. (SERA), MDxHealth SA (MDXH), PAVmed Inc. (PAVM), Co-Diagnostics, Inc. (CODX).